Ten daily fractions for partial breast irradiation. Long-term results of a prospective phase II trial
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ten daily fractions for partial breast irradiation. Long-term results of a prospective phase II trial
Authors
Keywords
-
Journal
Breast Journal
Volume 25, Issue 2, Pages 243-249
Publisher
Wiley
Online
2019-02-04
DOI
10.1111/tbj.13195
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Seven fractions to deliver partial breast irradiation: the toxicity is Low
- (2017) Marco Trovo et al. Radiation Oncology
- Long-Term Update of NRG Oncology RTOG 0319: A Phase 1 and 2 Trial to Evaluate 3-Dimensional Conformal Radiation Therapy Confined to the Region of the Lumpectomy Cavity for Stage I and II Breast Carcinoma
- (2016) Rachel Rabinovitch et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Accelerated partial breast irradiation with external beam radiotherapy
- (2016) Oliver J. Ott et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial
- (2015) Lorenzo Livi et al. EUROPEAN JOURNAL OF CANCER
- Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial
- (2015) Ian H Kunkler et al. LANCET ONCOLOGY
- Hypofractionation of partial breast irradiation using radiobiological models
- (2015) Michele Avanzo et al. Physica Medica-European Journal of Medical Physics
- Decline of Cosmetic Outcomes Following Accelerated Partial Breast Irradiation Using Intensity Modulated Radiation Therapy: Results of a Single-Institution Prospective Clinical Trial
- (2014) Adam L. Liss et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Toxicity and cosmesis following partial breast irradiation consisting of 40 Gy in 10 daily fractions
- (2013) Marco Trovo et al. BREAST
- Five-Year Outcomes, Cosmesis, and Toxicity With 3-Dimensional Conformal External Beam Radiation Therapy to Deliver Accelerated Partial Breast Irradiation
- (2013) Núria Rodríguez et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Interim Cosmetic and Toxicity Results From RAPID: A Randomized Trial of Accelerated Partial Breast Irradiation Using Three-Dimensional Conformal External Beam Radiation Therapy
- (2013) Ivo A. Olivotto et al. JOURNAL OF CLINICAL ONCOLOGY
- Lumpectomy Plus Tamoxifen With or Without Irradiation in Women Age 70 Years or Older With Early Breast Cancer: Long-Term Follow-Up of CALGB 9343
- (2013) Kevin S. Hughes et al. JOURNAL OF CLINICAL ONCOLOGY
- Patient Preferences and Physician Practice Patterns Regarding Breast Radiotherapy
- (2011) David J. Hoopes et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Complication probability model for subcutaneous fibrosis based on published data of partial and whole breast irradiation
- (2011) Michele Avanzo et al. Physica Medica-European Journal of Medical Physics
- Toxicity of Three-Dimensional Conformal Radiotherapy for Accelerated Partial Breast Irradiation
- (2009) Jaroslaw T. Hepel et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Initial Efficacy Results of RTOG 0319: Three-Dimensional Conformal Radiation Therapy (3D-CRT) Confined to the Region of the Lumpectomy Cavity for Stage I/ II Breast Carcinoma
- (2009) Frank Vicini et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Unacceptable Cosmesis in a Protocol Investigating Intensity-Modulated Radiotherapy With Active Breathing Control for Accelerated Partial-Breast Irradiation
- (2009) Reshma Jagsi et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started